Jacobs & CO Eli Lilly & CO Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Jacobs & CO holds 21,745 shares of LLY stock, worth $16.2 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares

21,745

Previous 21,976 1.05%

Holding current value

$16.2 Million

Previous $19.9 Million 3.18%

% of portfolio

1.93%

Previous 2.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$772.14 - $960.02 $178,364 - $221,764	-231 Reduced 1.05%	21,745 $19.3 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $401,577 - $503,608	-554 Reduced 2.46%	21,976 $19.9 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $508,107 - $679,776	-858 Reduced 3.67%	22,530 $17.5 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $663,314 - $781,961	-1,263 Reduced 5.12%	23,388 $13.6 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $395,142 - $544,763	-909 Reduced 3.56%	24,651 $13.2 Million
Q2 2023 Jul 11, 2023	SELL	$350.74 - $468.98 $657,286 - $878,868	-1,874 Reduced 6.83%	25,560 $12 Million
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $90,082 - $105,797	290 Added 1.07%	27,434 $9.42 Million
Q4 2022 Jan 13, 2023	SELL	$321.55 - $374.67 $83,603 - $97,414	-260 Reduced 0.95%	27,144 $9.93 Million
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $166,918 - $190,220	-563 Reduced 2.01%	27,404 $8.86 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $100,064 - $117,489	-359 Reduced 1.27%	27,967 $9.07 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $113,824 - $141,455	-485 Reduced 1.68%	28,326 $8.11 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $169,761 - $210,675	-755 Reduced 2.55%	28,811 $7.96 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $88,861 - $109,356	-401 Reduced 1.34%	29,566 $6.83 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $209,076 - $270,439	-1,158 Reduced 3.72%	29,967 $6.88 Million
Q1 2021 Apr 05, 2021	SELL	$164.32 - $212.72 $96,291 - $124,653	-586 Reduced 1.85%	31,125 $5.81 Million
Q4 2020 Jan 12, 2021	BUY	$130.46 - $172.63 $106,324 - $140,693	815 Added 2.64%	31,711 $5.35 Million
Q3 2020 Dec 03, 2020	SELL	$146.22 - $169.13 $243,894 - $282,108	-1,668 Reduced 5.12%	30,896 $4.57 Million
Q2 2020 Jul 09, 2020	SELL	$136.42 - $164.18 $17,871 - $21,507	-131 Reduced 0.4%	32,564 $5.35 Million
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $68,453 - $84,726	-575 Reduced 1.73%	32,695 $4.54 Million
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $137,285 - $170,040	1,284 Added 4.01%	33,270 $4.37 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $78,063 - $84,912	-731 Reduced 2.23%	31,986 $3.58 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $99,711 - $116,388	900 Added 2.83%	32,717 $3.62 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $687,227 - $808,917	-6,174 Reduced 16.25%	31,817 $4.13 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $225,461 - $252,584	-2,129 Reduced 5.31%	37,991 $4.4 Million
Q3 2018 Oct 23, 2018	SELL	$85.86 - $107.31 $200,654 - $250,783	-2,337 Reduced 5.5%	40,120 $4.31 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $4,769 - $5,473	-63 Reduced 0.15%	42,457 $3.62 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $104,413 - $123,253	-1,407 Reduced 3.2%	42,520 $3.29 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $50,393 - $54,052	-615 Reduced 1.38%	43,927 $3.71 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.43 Million - $3.81 Million	44,542	44,542 $3.81 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account